Electrochemical molecular beacon DNA biosensor for the detection and discrimination of the DF508 cystic fibrosis mutation

2011 ◽  
Vol 662 (2) ◽  
pp. 322-327 ◽  
Author(s):  
Hany Nasef ◽  
Valerio Beni ◽  
Ciara K. O’Sullivan
2010 ◽  
Vol 26 (2) ◽  
pp. 307-313 ◽  
Author(s):  
Valerio Beni ◽  
Karen Hayes ◽  
Teresa Mairal Lerga ◽  
Ciara K. O'Sullivan

QJM ◽  
2000 ◽  
Vol 93 (5) ◽  
pp. 313-315 ◽  
Author(s):  
K.P. Dawson ◽  
P.M. Frossard

2008 ◽  
Vol 15 (1) ◽  
pp. 62-69 ◽  
Author(s):  
Luísa S. Pissarra ◽  
Carlos M. Farinha ◽  
Zhe Xu ◽  
André Schmidt ◽  
Patrick H. Thibodeau ◽  
...  

1993 ◽  
Vol 2 (3) ◽  
pp. 315-316 ◽  
Author(s):  
Damjan Glavac ◽  
Metka Ravnik-Glavac ◽  
Michael Dean

Human Biology ◽  
2001 ◽  
Vol 73 (2) ◽  
pp. 191-203 ◽  
Author(s):  
Tuncer Onay ◽  
Julian Zielenski ◽  
Ozlem Topaloglu ◽  
Nalan Gokgoz ◽  
Hulya Kayserili ◽  
...  

1994 ◽  
Vol 40 (10) ◽  
pp. 1972-1974 ◽  
Author(s):  
G J Tsongalis ◽  
G Faber ◽  
F G Dalldorf ◽  
K J Friedman ◽  
L M Silverman ◽  
...  

Abstract A case of adenocarcinoma of the pancreas and mild lung disease in a 39-year-old man homozygous for the delta F508 cystic fibrosis mutation is presented. Cystic fibrosis is the most common lethal genetic disease in Caucasians, and is most commonly associated with severe obstructive lung disease. To our knowledge, this is only the fifth case of adenocarcinoma of the pancreas in a CF patient to be reported and the first case for which molecular data are available. The rare incidence of this type of malignancy in the general population suggests a possible association of CF with this malignant disease.


Sign in / Sign up

Export Citation Format

Share Document